Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Oncology Report

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.10.4.827PMID 12792730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.

  2000cited by this paper
• Prognostic Significance of p27kip1 Protein Expression and Spontaneous Apoptosis in Patients with Colorectal Adenocarcinomas

  2000cited by this paper
• Apoptosis in relation to proliferating cell nuclear antigen and Dukes' stage in colorectal adenocarcinoma.

  1999cited by this paper
• Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.

  1998cited by this paper
• Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.

  1998cited by this paper
• Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.

  1998cited by this paper
• Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.

  1998cited by this paper
• Apoptosis as a Prognostic Factor in Colorectal Carcinoma

  1998cited by this paper
• p27 expression and gastric carcinoma

  1997cited by this paper
• Aberrant p27kip1 expression in endocrine and other tumors.

  1997cited by this paper
• The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

  1997cited by this paper
• Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

  1997cited by this paper
• Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c‐myc and bcl‐2 protein products

  1997cited by this paper
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997cited by this paper
• Deregulated expression of p27(Kip1) in human breast cancers.

  1997cited by this paper
• Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer

  1997cited by this paper
• lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin

  1994cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper
• Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer

  1993cited by this paper
• Analysis of proliferative activity using anti‐proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy

  1993cited by this paper
• Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

  1993cited by this paper
• Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry.

  1993cited by this paper
• Ki‐67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations

  1988cited by this paper

• Prognostic significance of p27 in colorectal cancer: a meta-analysis and bioinformatics analysis

  2024cites this paper
• Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature)

  2019cites this paper
• Apoptosis as a Prognostic Factor in Colorectal Carcinoma: Comparison of TUNEL Method and Immunohistochemical Expression of Caspase-3

  2019cites this paper
• Bax protein as a prognostic marker in colorectal cancer: characteristics, role in apoptosis regulation, and correlation with disease prognosis (literature review)

  2019cites this paper
• Clinical significances of p27 in digestive tract cancers: a comprehensive analysis on immunohistochemistry staining, published literatures, microarray and RNA-seq data

  2018cites this paper
• The B56γ3 regulatory subunit-containing protein phosphatase 2A outcompetes Akt to regulate p27KIP1 subcellular localization by selectively dephosphorylating phospho-Thr157 of p27KIP1

  2015cites this paper
• Roxithromycin reduces the viability of cultured airway smooth muscle cells from a rat model of asthma.

  2014cites this paper
• Notch1-dependent regulation of p27 determines cell fate in colorectal cancer.

  2013cites this paper
• In vivo antitumor effects of 4,7-dimethoxy-5-methyl-1,3-benzodioxole isolated from the fruiting body of Antrodia camphorata through activation of the p53-mediated p27/Kip1 signaling pathway.

  2012cites this paper
• ANTI-APOPTOTIC EFFECTS OF SPEEDYRINGO IN NEURODEGENERATION Ayşegül ÜNAL NOVEMBER 2012 ISTANBUL TECHNICAL UNIVERSITY GRADUATE SCHOOL OF SCIENCE ENGINEERING AND TECHNOLOGY ANTI-APOPTOTIC EFFECTS OF SPEEDYRINGO IN NEURODEGENERATION Ph.D. THESIS

  2012cites this paper
• In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer.

  2010cites this paper
• Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.

  2010cites this paper
• Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target.

  2010cites this paper
• A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival

  2009influential citation
• A Cohort Study of p 27 Localization in Colon Cancer , Body Mass Index , and Patient Survival

  2009influential citation
• Expression patterns of cyclins D1, E and cyclin‐dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki‐67 and PCNA) and clinicopathological features

  2008cites this paper
• Apoptosis and non-apoptotic deaths in cancer development and treatment response.

  2008cites this paper
• What Do the Clinical Data Tell Us About the Role of Apoptosis in Sensitivity to Cancer Therapy

  2008cites this paper
• The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

  2008cites this paper
• Cytoplasmic localization of p27 (CDKN1B / KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability and CpG island methylator phenotype (CIMP)

  2007cites this paper
• Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.

  2007cites this paper
• Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP

  2007cites this paper
• p27kip1 Deficiency Impairs G2/M Arrest in Response to DNA Damage, Leading to an Increase in Genetic Instability

  2007cites this paper
• Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.

  2007cites this paper
• Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.

  2007cites this paper
• Prognostic Significance of DCC and p27Kip1 in Colorectal Cancer

  2005cites this paper
• An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions.

  2005cites this paper
• Colorectal Cancer: Molecular Staging Models that Charactrize Risk and Enhance Prognosis.

  2004cites this paper
• Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and Clinical Data Tell Us?

  2003cites this paper